Literature DB >> 31641069

Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis.

Lindsay S Cahill1, Monan Angela Zhang2, Valeria Ramaglia2, Heather Whetstone3, Melika Pahlevan Sabbagh2, Tae Joon Yi2, Laura Woo1, Thomas S Przybycien2, Marina Moshkova4, Fei Linda Zhao2, Olga L Rojas2, Josephine Gomes2, Stefanie Kuerten5, Jennifer L Gommerman2, John G Sled1,6, Shannon E Dunn7,4,8,9.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is the most common model of multiple sclerosis (MS). This model has been instrumental in understanding the events that lead to the initiation of central nervous system (CNS) autoimmunity. Though EAE has been an effective screening tool for identifying novel therapies for relapsing-remitting MS, it has proven to be less successful in identifying therapies for progressive forms of this disease. Though axon injury occurs in EAE, it is rapid and acute, making it difficult to intervene for the purpose of evaluating neuroprotective therapies. Here, we describe a variant of spontaneous EAE in the 2D2 T cell receptor transgenic mouse (2D2+ mouse) that presents with hind-limb clasping upon tail suspension and is associated with T cell-mediated inflammation in the posterior spinal cord and spinal nerve roots. Due to the mild nature of clinical signs in this model, we were able to maintain cohorts of mice into middle age. Over 9 mo, these mice exhibited a relapsing-remitting course of hind-limb clasping with the development of progressive motor deficits. Using a combined approach of ex vivo magnetic resonance (MR) imaging and histopathological analysis, we observed neurological progression to associate with spinal cord atrophy, synapse degradation, and neuron loss in the gray matter, as well as ongoing axon injury in the white matter of the spinal cord. These findings suggest that mild EAE coupled with natural aging may be a solution to better modeling the neurodegenerative processes seen in MS.

Entities:  

Keywords:  multiple sclerosis model; neurodegeneration; progressive

Mesh:

Substances:

Year:  2019        PMID: 31641069      PMCID: PMC6842635          DOI: 10.1073/pnas.1915141116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  71 in total

1.  A unified statistical approach to deformation-based morphometry.

Authors:  M K Chung; K J Worsley; T Paus; C Cherif; D L Collins; J N Giedd; J L Rapoport; A C Evans
Journal:  Neuroimage       Date:  2001-09       Impact factor: 6.556

2.  Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.

Authors:  Iliana Michailidou; Janske G P Willems; Evert-Jan Kooi; Corbert van Eden; Stefan M Gold; Jeroen J G Geurts; Frank Baas; Inge Huitinga; Valeria Ramaglia
Journal:  Ann Neurol       Date:  2015-05-11       Impact factor: 10.422

3.  Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator.

Authors:  M J West; L Slomianka; H J Gundersen
Journal:  Anat Rec       Date:  1991-12

4.  Peripheral selection of the T cell repertoire.

Authors:  B Rocha; H von Boehmer
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

5.  Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Authors:  Ludwig Kappos; Amit Bar-Or; Bruce A C Cree; Robert J Fox; Gavin Giovannoni; Ralf Gold; Patrick Vermersch; Douglas L Arnold; Sophie Arnould; Tatiana Scherz; Christian Wolf; Erik Wallström; Frank Dahlke
Journal:  Lancet       Date:  2018-03-23       Impact factor: 79.321

6.  Approaches to normalization of spinal cord volume: application to multiple sclerosis.

Authors:  Brian C Healy; Ashish Arora; Douglas L Hayden; Antonia Ceccarelli; Shahamat S Tauhid; Mohit Neema; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-08-19       Impact factor: 2.486

7.  Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation.

Authors:  Natalia B Pikor; Jillian L Astarita; Leslie Summers-Deluca; Georgina Galicia; Joy Qu; Lesley A Ward; Susan Armstrong; Claudia X Dominguez; Deepali Malhotra; Brendan Heiden; Robert Kay; Valera Castanov; Hanane Touil; Louis Boon; Paul O'Connor; Amit Bar-Or; Alexandre Prat; Valeria Ramaglia; Samuel Ludwin; Shannon J Turley; Jennifer L Gommerman
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

8.  TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis.

Authors:  Yasmina Laouar; Terrence Town; David Jeng; Elise Tran; Yisong Wan; Vijay K Kuchroo; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

9.  Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.

Authors:  Gareth Pryce; Janet K O'Neill; J Ludovic Croxford; Sandra Amor; Deborah J Hankey; Emma East; Gavin Giovannoni; David Baker
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

10.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

View more
  2 in total

1.  Functional divergence of the two Elongator subcomplexes during neurodevelopment.

Authors:  Monika Gaik; Marija Kojic; Megan R Stegeman; Tülay Öncü-Öner; Anna Kościelniak; Alun Jones; Ahmed Mohamed; Pak Yan Stefanie Chau; Sazia Sharmin; Andrzej Chramiec-Głąbik; Paulina Indyka; Michał Rawski; Anna Biela; Dominika Dobosz; Amanda Millar; Vann Chau; Aycan Ünalp; Michael Piper; Mark C Bellingham; Evan E Eichler; Deborah A Nickerson; Handan Güleryüz; Nour El Hana Abbassi; Konrad Jazgar; Melissa J Davis; Saadet Mercimek-Andrews; Sultan Cingöz; Brandon J Wainwright; Sebastian Glatt
Journal:  EMBO Mol Med       Date:  2022-06-13       Impact factor: 14.260

2.  Peroxisome Proliferator-Activated Receptor-δ Deficiency in Microglia Results in Exacerbated Axonal Injury and Tissue Loss in Experimental Autoimmune Encephalomyelitis.

Authors:  Ellinore R Doroshenko; Paulina C Drohomyrecky; Annette Gower; Heather Whetstone; Lindsay S Cahill; Milan Ganguly; Shoshana Spring; Tae Joon Yi; John G Sled; Shannon E Dunn
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.